Navigation Links
Francisella tularensis: Stopping a biological weapon
Date:7/27/2008

Scientists hope a vaccine is on the horizon for tularemia, a fatal disease caused by the pathogen Francisella tularensis, an organism of concern as a potential biological warfare agent. Until recently we knew very little about this bacterium. However, according to the August issue of the Journal of Medical Microbiology, research on the bacterium has been reinvigorated and rapid progress has been made in understanding how it causes disease.

Infection with F. tularensis can result in a variety of symptoms, depending on the route of infection. For example, infection via an insect bite can lead to a swollen ulcer or fever, chills, malaise, headaches and a sore throat. When infection occurs by eating contaminated food, symptoms can range from mild diarrhoea to an acute fatal disease. If inhaled, F. tularensis infections can have a 30% mortality rate if left untreated.

"Only very few bacteria are needed to cause serious disease," said Prof Petra Oyston from Dstl, Porton Down. "Because of this and the fact that tularemia can be contracted by inhalation, Francisella tularensis has been designated a potential biological weapon. Since the events of September 2001 and the subsequent anthrax attacks on the USA, concern about the potential misuse of dangerous pathogens including F. tularensis has increased. As a result, more funding has been made available for research on these organisms and has accelerated progress on developing medical countermeasures."

Tularemia circulates in rodents and animals like rabbits and hares. Outbreaks in humans often happen at the same time as outbreaks in these animals. The disease is probably transmitted by insects like mosquitoes, ticks and deer flies. People can also become infected by contact with contaminated food or water and by breathing in particles containing the bacteria. Farmers, hunters, walkers and forest workers are most at risk of contracting tularemia.

The
'/>"/>

Contact: Lucy Goodchild
l.goodchild@sgm.ac.uk
44-118-988-1843
Society for General Microbiology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Stopping unwanted cell death: Implications for drug discovery
2. Steps toward Stopping Autoimmune Disease
3. Tips on how to build a better home for biological parts
4. Genomics of large marine animals showcased in the biological bulletin
5. Securing the future of Europes biological data resources
6. Religion and the narrative of biological science
7. AIBS honors outstanding contributions to the biological sciences
8. Negligent, attentive mouse mothers show biological differences
9. Ancient DNA: reconstruction of the biological history of Aldaieta necropolis
10. U. Iowa study finds biological link between pain and fatigue
11. NYU dental professor discovers biological clock linking tooth growth to other metabolic processes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...(LRI) today named 12 new grant recipients for 2009...ovative work across a broad spectrum of lupus rese...lty, and potential to drive scientific discovery t...disease of systemic lupus. , The 2009 grants go ...ss the nation and include interdisciplinary and hi...
(Date:11/24/2009)...a protein that may help gut bacteria bind to the g...y probiotic producers to identify strains that are...otics need to interact with cells lining the gut t...surfaces in the gut they are more likely to stick ...Dr Nathalie Juge from the Institute of Food Resear...
(Date:11/24/2009)...remarkable class of ring-shaped protein motors has...erkeley National Laboratory (Berkeley Lab) using a... at the Advanced Light Source (ALS). These protein...replication, and are vital to the survival of all ...ch as the human papillomavirus, which has been lin...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane 12800 1Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane 12800 2Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane 12800 3Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax 26amp 3B 238482 3B 3A the First Automated Chemistry Development Tool That Re 12796 1Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax 26amp 3B 238482 3B 3A the First Automated Chemistry Development Tool That Re 12796 2HealthSource of Chicago 3A New Techniques for Back Pain Relief in Chicago 50144 1HealthSource of Chicago 3A New Techniques for Back Pain Relief in Chicago 50144 2HealthSource of Chicago 3A New Techniques for Back Pain Relief in Chicago 50144 3HealthSource of Chicago 3A New Techniques for Back Pain Relief in Chicago 50144 4
..., Professor of Molecular Biophysics and Biochemist...gh Research Institute Award. , The award is given... Biology to recognize outstanding scientific contr...careers. , Strobel will give the award lecture, t...osomes, and Riboswitches, at the societys annual m...
...lobal Innovation Imperatives (Gii) project swung i... first session at the American Chemical Societys (... joint collaboration between the ACS Committee on ... Industry, seeks to combat worldwide health, envir...-based solutions, particularly those relating to c...
...nt of the children in the U.S. carry backpacks. Ty...ourth of the childs body weight (22 percent) and w...sician researchers examined the effect heavy-loade... the straps can significantly increase pressure wh...d that strap pressures with loads as small as ten ...
Other Biology News:Yale University's Strobel recognized for work on RNA 2At ACS' national meeting, global initiative set to tackle water issues 2Backpack straps can decrease blood flow in the shoulder and arm 2
(Date:11/30/2009)...STERDAM, November 30 Els..., medical and technical products and services,tod...rehensive biomedical,database which holds over 20 ...e, peer reviewed journals. , Embase has l...omedical,and pharmaceutical insights. Now, new dev...
(Date:11/27/2009)...ire-FirstCall/ -- Stallergenes has been,granted Eu...s and children,through a Mutual Recognition Proced...as been marketed, was the reference Member state. ..., Belgium, Bulgaria, Cyprus, the,Czech Republic, E... Italy,Latvia, Lithuania, Luxembourg, Malta, the ...
(Date:11/25/2009)...re/ -- Biotech firm Replikins Ltd., which has anal...ndemic through the prediction, outbreak, and progr... latest biochemical analysis of the virus. The new... Flu") virus has dropped from its peak of 3.7 (s.d...spring of 2009 to resting non-epidemic levels this...
(Date:11/25/2009)...Newswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a l...ed today that it executed,a joint venture (JV) agr...ology Co., Ltd. (Sinovac Dalian). The JV will rese... vaccines. Sinovac will contribute its expertise,a...rld-class vaccines; the,other party will bring its...
Breaking Biology Technology:Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...Q3 Results, FRANKLIN, Mass., Nov. 20 Echo Therap...nced financial results for the,third quarter ended...er 30,2007, net loss was $8,677,000 or $.70 per sh... the same period in 2006. For the nine months ende... $1.05 per share, compared,to $4,229,000 or $1.60 ...
...mentation Technology, Ser...ris has been selected as,the first awarded supplie...,by Provista, one of the nation,s leading group pu...nt, Spheris will provide Provista customers with,a... in addition to,industry-leading outsource service...
...ia E to be Featured, HOFFMAN ESTATES, Ill., Nov. ...r additions to existing,technology, Siemens Medica... is,propelling the field of molecular medicine to ...ing oncology, neurology and cardiology, Siemens wi...nologies at the 93rd,Scientific Assembly and Annua...
Other Biology Technology:Echo Therapeutics Reports Third Quarter 2007 Results 2Echo Therapeutics Reports Third Quarter 2007 Results 3Echo Therapeutics Reports Third Quarter 2007 Results 4Echo Therapeutics Reports Third Quarter 2007 Results 5Echo Therapeutics Reports Third Quarter 2007 Results 6Provista Awards Agreement to Spheris 2Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007 2Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007 3Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007 4Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007 5
Anti-AANAT Antibody, Unconjugated from CHEMICON
Mouse Anti-TUP1 Monoclonal Antibody, Unconjugated, Clone 10 from Exalpha Biologicals, Inc.
Mouse Anti-Human NANS Monoclonal Antibody, Unconjugated, Clone 3G6 from ABR-Affinity BioReagents
Mouse Anti-C2 Monoclonal Antibody, Unconjugated, Clone 050-04 from Abcam
Biology Products: